| Name | InvestmentAccountedForUsingEquityMethod |
|---|---|
| Namespace | http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full |
| Prefix | ifrs-full |
| Data type | xbrli:monetaryItemType |
| Period type | instant |
| Substitution Group | xbrli:item |
| Balance | debit |
| Nillable | True |
| Abstract | False |
| Text | Lang | Role | Container role |
|---|---|---|---|
| Investments accounted for using equity method | en | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
| Total investments accounted for using equity method | en | http://www.xbrl.org/2003/role/totalLabel | http://www.xbrl.org/2003/role/link |
| The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]] | en | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
| Investeringen die administratief werden verwerkt volgens de vermogensmutatiemethode | nl | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
| Het bedrag aan investeringen die administratief werden verwerkt volgens de vermogensmutatiemethode. De vermogensmutatiemethode is een methode voor administratieve verwerking waarbij de investering aanvankelijk tegen kostprijs wordt opgenomen, en vervolgens wordt aangepast om rekening te houden met de wijziging van het aandeel van de investeerder in de nettoactiva van de deelneming na de overname. De winst of het verlies van de investeerder omvat zijn aandeel in de winst of het verlies van de deelneming. De overige onderdelen van het totaalresultaat van de investeerder omvatten zijn aandeel in de overige onderdelen van het totaalresultaat van de deelneming. [Zie: gewaardeerd tegen kostprijs [member]] | nl | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
| Name | Value | Role |
|---|---|---|
| Name | IAS | http://www.xbrl.org/2003/role/disclosureRef |
| Number | 1 | http://www.xbrl.org/2003/role/disclosureRef |
| IssueDate | 2019-01-01 | http://www.xbrl.org/2003/role/disclosureRef |
| Paragraph | 54 | http://www.xbrl.org/2003/role/disclosureRef |
| Subparagraph | e | http://www.xbrl.org/2003/role/disclosureRef |
| URI | http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_54_e&doctype=Standard | http://www.xbrl.org/2003/role/disclosureRef |
| URIDate | 2019-03-27 | http://www.xbrl.org/2003/role/disclosureRef |
| Name | IFRS | http://www.xbrl.org/2003/role/disclosureRef |
| Number | 12 | http://www.xbrl.org/2003/role/disclosureRef |
| IssueDate | 2019-01-01 | http://www.xbrl.org/2003/role/disclosureRef |
| Paragraph | B16 | http://www.xbrl.org/2003/role/disclosureRef |
| URI | http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B16&doctype=Appendix&subtype=B | http://www.xbrl.org/2003/role/disclosureRef |
| URIDate | 2019-03-27 | http://www.xbrl.org/2003/role/disclosureRef |
| Name | IFRS | http://www.xbrl.org/2003/role/disclosureRef |
| Number | 8 | http://www.xbrl.org/2003/role/disclosureRef |
| IssueDate | 2019-01-01 | http://www.xbrl.org/2003/role/disclosureRef |
| Paragraph | 24 | http://www.xbrl.org/2003/role/disclosureRef |
| Subparagraph | a | http://www.xbrl.org/2003/role/disclosureRef |
| URI | http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2019-en-r&anchor=para_24_a&doctype=Standard | http://www.xbrl.org/2003/role/disclosureRef |
| URIDate | 2019-03-27 | http://www.xbrl.org/2003/role/disclosureRef |
| Name | Relation Type | Role | |
|---|---|---|---|
ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod | summation-item | http://www.esma.europa.eu/xbrl/role/all/ias_1_role-800100 | |
ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod | summation-item | http://www.esma.europa.eu/xbrl/role/all/ias_1_role-800100 |